Resveratrol inhibits the activity of equine neutrophil myeloperoxidase by a direct interaction with the enzyme

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 20, 2007, Pages 8080-8087

  Kohnen, Stephan ^a   Franck, Thierry ^a   Van Antwerpen, Pierre ^c   Boudjeltia, Karim Zouaoui ^c   Mouithys Mickalad, Ange ^a   Deby, Carol ^a   Moguilevsky, Nicole ^d   Deby Dupont, Ginette ^a,b   Lamy, Maurice ^a,b   Serteyn, Didier ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Myeloperoxidase; Neutrophils; Resveratrol; SIEFED

Indexed keywords

EQUIDAE;

ENZYME INHIBITOR; PEROXIDASE; REACTIVE OXYGEN METABOLITE; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; ARTICLE; DRUG ANTAGONISM; ENZYMOLOGY; HORSE; METABOLISM; NEUTROPHIL;

ANIMALS; ENZYME INHIBITORS; HORSES; NEUTROPHILS; PEROXIDASE; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 38349016865     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf071741n     Document Type: Article

References (51)

1. Frémont, L. Biological effects of resveratrol. Life Sci. 2003, 66, 663-673.
2. Pervaiz, S. Resveratrol: from grapevines to mammalian biology. FASEB J. 2003, 17, 1975-1985.
3. Das, D. K.; Maulik, N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol. Interventions 2006, 6, 36-17.
4. Kaplan, S.; Bisleri, G.; Morgan, J. A.; Cheema, F. H.; Oz, M. C. Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury. Ann. Thorac. Surg. 2005, 80, 2242-2249.
5. Mokni, M.; Elkahoui, S.; Limam, F.; Amri, M.; Aouani, E. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem. Res. 2007, 32, 981-987.
6. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W.; Fong, H. H.; Farnsworth, N.R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275, 218-220.
7. Martin, A. R.; Villegas, I.; Sánchez-Hidalgo, M.; Alarcón de la Lastra, C. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br. J. Pharmacol. 2006, 147, 873885..
8. Deby-Dupont, G.; Mouithys-Mickalad, A.; Serteyn, D.; Lamy, M.; Deby, C. Resveratrol and curcumin reduce the respiratory burst of Chlamydia-primed THP-1 cells. Biochem. Biophys. Res. Commun. 2005, 333, 21-27.
9. Saikku, P.; Leinonen, M.; Mattila, K.; Ekman, M. R.; Nieminen, M. S.; Makela, P. H.; Huttunen, J. K.; Valtonen, V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988, 2, 983986..
10. Cavallaro, A.; Ainis, T.; Bottari, C.; Fimiani, V. Effect of resveratrol on some activities of isolated and in whole blood human neutrophils. Physiol. Res. 2003, 52, 555-562.
11. Klebanoff, S. J. Myeloperoxidase: friend and foe. J. Leukocyte Biol. 2005, 77, 598-625.
12. Furtmüller, P. G.; Burner, U.; Obinger, C. Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate. Biochemistry 1998, 37, 17923-17930.
13. Furtmuller, P. G.; Obinger, C.; Hsuanyu, Y.; Dunford, H. B. Mechanism of reaction of myeloperoxidase with hydrogen peroxide and chloride ion. Eur. J. Biochem. 2000, 267, 5858-5864.
14. Furtmuller, P. G.; Burner, U.; Regelsberger, G.; Obinger, C. Spectral and kinetic studies on the formation of eosinophil peroxidase compound I and its reaction with halides and thiocyanate. Biochemistry 2000, 39, 15578-15584.
15. Podrez, E. A.; Abu-Soud, H. M.; Hazen, S. L. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radical Biol. Med. 2000, 28, 1717-1725.
16. Sampson, J. B.; Ye, Y. Z.; Rosen, H.; Beckman, J. S. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch. Biochem. Biophys. 1998, 356, 207-213.
17. Burner, U.; Furtmuller, P. G.; Kettle, A. J.; Koppenol, W. H.; Obinger, C. Mechanism of reaction of myeloperoxidase with nitrite. J. Biol. Chem. 2000, 275, 20597-20601.
18. Mathy-Hartert, M.; Damas, P.; Nys, M.; Deby-Dupont, G.; Canivet, J. L.; Ledoux, D.; Lamy, M. Nitrated proteins in bronchoalveolar lavage fluid of patients at risk of ventilator-associated bronchopneumonia. Eur. Respir. J. 2000, 16, 296-301.
19. Zhang, R.; Brennan, M. L.; Shen, Z.; MacPherson, J. C.; Schmitt, D.; Molenda, C. E.; Hazen, S. L. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J. Biol. Chem. 2002, 277, 46116-46122.
20. Deby-Dupont, G.; Deby, C.; Lamy, M. Neutrophil myeloperoxidase revisited: it's role in health and disease. Intensivmed. 1999, 36, 500-513.
21. 2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur. J. Biochem. 2000, 267, 4495-4503.
22. Franck, T.; Grulke, S.; Deby-Dupont, G.; Deby, C.; Duvivier, H.; Peters, F.; Serteyn, D. Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood. J. Vet. Diagn. Invest. 2005, 17, 412-419.
23. Grulke, S.; Benbarek, H.; Caudron, I.; Deby-Dupont, G.; Mathy-Hartert, M.; Farnir, F.; Deby, C.; Lamy, M.; Serteyn, D. Plasma myeloperoxidase level and polymorphonuclear leukocyte activation in horses suffering from large intestinal obstruction requiring surgery: preliminary results. Can. J. Vet. Res. 1999, 63, 142-147.
24. Weiss, D. J.; Evanson, O. A.; McClenahan, D.; Fagliari, J. J.; Jenkins, K. Evaluation of platelet activation and platelet-neutrophil aggregates in ponies with alimentary laminitis. Am. J. Vet. Res. 1997, 58, 1376-1380.
25. Deaton, C. M.; Marlin, D. J.; Smith, N. C.; Smith, K. C.; Newton, R. J.; Gower, S. M.; Cade, S. M.; Roberts, C. A.; Harris, P. A.; Schroter, R. C.; Kelly, F. J. Breath condensate hydrogen peroxide correlates with both airway cytology and epithelial lining fluid ascorbic acid concentration in the horse. Free Radical Res. 2004, 38, 201-208.
26. Jantschko, W.; Furtmüller, P. G.; Zederbauer, M.; Neugschwandtner, K.; Lehner, I.; Jakopitsch, C.; Arnhold, J.; Obinger, C. Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design. Biochem. Pharmacol. 2005, 69, 1149-1157.
27. 2/nitrite systems in human saliva and characterization of an oxidation product of quercetin formed during the inhibition. J. Agric. Food Chem. 2005, 53, 3265-3272.
28. Schewe, T.; Sies, H. Myeloperoxidase-induced lipid peroxidation of LDL in the presence of nitrite. Protection by cocoa flavanols. Biofactors 2005, 24, 49-58.
29. Franck, T.; Kohnen, S.; Deby-Dupont, G.; Grulke, S.; Deby, C.; Serteyn, D. A specific method for measurement of equine active myeloperoxidase in biological samples and in in vitro tests. J. Vet. Diagn. Invest. 2006, 18, 326-334.
30. Pycock, J. F.; Allen, W. E.; Morris, T. H. Rapid, single-step isolation of equine neutrophils on a discontinuous Percoll density gradient. Res. Vet. Sci. 1987, 42, 411-412.
31. Mathy-Hartert, M.; Bourgeois, E.; Grulke, S.; Deby-Dupont, G.; Caudron, I.; Deby, C.; Lamy, M.; Serteyn, D. Purification of myeloperoxidase from equine polymorphonuclear leucocytes. Can. J. Vet. Res. 1998, 62, 127-32.
32. Benbarek, H.; Deby-Dupont, G.; Deby, C.; Caudron, I.; Mathy-Hartert, M.; Lamy, M.; Serteyn, D. Experimental model for the study by chemiluminescence of the activation of isolated equine leucocytes. Res. Vet. Sci. 1996, 61, 59-64.
33. Nève, J.; Parij, N.; Moguilevsky, N. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs investigated with a human recombinant enzyme. Eur. J. Pharmacol. 2001, 417, 37-43.
34. 2/Chloride system to inhibit LDL oxidation. Biochem. Biophys. Res. Commun. 2005, 337, 82-88.
35. Slater, S. J.; Seiz, J. L.; Cook, A. C.; Stagliano, B. A.; Buzac, C. J. Inhibition of protein kinase C by resveratrol. Biochem. Biophys. Acta 2003, 1637, 59-69.
36. Tsai, S. H.; Lin-Shiau, S. Y.; Lin, J. K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. 1999, 126, 673-680.
37. Leonard, S. S.; Xia, C.; Jiang, B.-H.; Stinefelt, B.; Klandorf, H.; Harris, G. K.; Shi, X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 2003, 309, 1017-1026.
38. Fiedler, T. J.; Davey, C. A.; Fenna, R. E. X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 Å resolution. J. Biol. Chem. 2000, 275, 11964-11971.
39. Szewczuk, L. M.; Penning, T. M. Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: A structure-activity relationship study. J. Nat. Prod. 2004, 67, 1777-1782.
40. Szewczuk, L. M.; Forti, L.; Stivala, L. A.; Penning, T. M. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: A mechanistic approach to the design of COX-1 selective agents. J. Biol. Chem. 2004, 279, 22727-22737.
41. Fan, X.; Mattheis, J. P. Inhibition of oxidative and antioxidative enzymes by trans-resveratrol. J. Food Sci. 2001, 66, 200-203.
42. Takaya, Y.; Terashima, K.; Ito, J.; He, Y. H.; Tateoka, M.; Yamaguchi, N.; Niwa, M. Biomimic transformation of resveratrol. Tetrahedron 2005, 61, 10285-10290.
43. Gilabert, M. A.; Hiner, A. N. P.; Garcia-Ruiz, P. A.; Tudela, J.; Garcia-Molina, F.; Acosta, M.; Garcia-Canovasa, F.; Rodriguez-Lopez, J. N. Differential substrate behaviour of phenol and aniline derivatives during oxidation by horseradish peroxidase: kinetic evidence for a two-step mechanism. Biochim. Biophys. Acta 2004, 1699, 235-243.
44. Gilabert, M. A.; Fenoll, L. G.; Garcia-Molina, F.; Tudela, J.; Garcia-Canovas, F.; Rodriguez-Lopez, J. N. Kinetic characterization of phenol and aniline derivates as substrates of peroxidase. Biol. Chem. 2004, 385, 795-800.
45. Gilabert, M. A.; Fenoll, L. G.; Garcia-Molina, F.; Garcia-Ruiz, P. A.; Tudela, J.; Garcia-Canovas, F.; Rodriguez-Lopez, J. N. Stereospecificity of horseradish peroxidase. Biol. Chem. 2004, 385, 1177-1184.
46. Fenoll, L. G.; Garcia-Mollina, F.; Gilabert, M. A.; Varon, R.; Garcia-Ruiz, P. A.; Tudela, J.; Garcia-Canovas, F.; Rodriguez-Lopez, J. N. Interpretation of the reactivity of peroxidase compound II with phenols and anilines using the Marcus equation. Biol. Chem. 2005, 386, 351-360.
47. Pezet, R.; Perret, C.; Jean-Denis, J. B.; Tabacchi, R.; Gindro, K.; Viret, O. delta-viniferin, a resveratrol dehydrodimer: One of the major stilbenes synthesized by stressed grapevine leaves. J. Agric. Food Chem. 2003, 51, 5488-5492.
48. Nicotra, S.; Cramarossa, M. R.; Mucci, A.; Pagnoni, U. M.; Riva, S.; Forti, L. Biotransformation of resveratrol: synthesis of transdehydrodimers catalyzed by laccases from Myceliophtora thermophyla and from Trametes pubescens. Tetrahedron 2004, 60, 595-600.
49. Espin, J. C.; Wichers, H. J. Study of the oxidation of resveratrol catalyzed by polyphenol oxidase. Effect of polyphenol oxidase, laccase and peroxidase on the antiradical capacity of resveratrol. J. Food Biochem. 2000, 24, 225-250.
50. Kim, Y. M.; Yun, J.; Lee, C. K.; Lee, H.; Min, K. R.; Kim, Y. Oxyresveratrol and hydroxystilbene compounds: Inhibitory effect on tyrosinase and mechanism of action. J. Biol. Chem. 2002, 277, 16340-16344.
51. Ohguchi, K.; Tanaka, T.; Kido, T.; Baba, K.; Iinuma, M.; Matsumoto, K.; Akao, Y.; Nozawa, Y. Effects of hydroxystilbene derivatives on tyrosinase activity. Biochem. Biophys. Res. Commun. 2003, 307, 861-863.